From Concept to Market… Navigating the Pathway Date: 03/06/2015 Time: 4:30 am – 5:30 am Location: 123 Snell Library Speaker: Eugene Seymour, CEO, Nanoviricides, Inc. From Concept to Market… Navigating the Pathway The challenges of taking a concept from idea through funding, through development, testing and regulatory approval and then on to market are daunting…
Category: Events
The National Nanotechnology Initiative
The National Nanotechnology Initiative Date: 03/06/2015 Time: 3:30 pm – 4:30 pm Location: 123 Snell Library Speaker: Michael Meador, Ph.D., Director, National Nanotechnology Coordination Office The National Nanotechnology Initiative The National Nantechnology Initiative (NNI) coordinates nanotechnology R&D efforts and funding across 20 government departments and agencies. With the support of the NNI, nanotechnology R&D is…
Strategic Goal Setting as a Biotech CEO
Strategic Goal Setting as a Biotech CEO Date: 02/27/2015 Time: 3:30 pm – 4:30 pm Location: 123 Snell Library Speaker: Guillaume Pfefer, Ph.D., Former President & CEO, Kala Pharmaceuticals The talk will cover first hand experience with leading a venture-backed biotech from strategy reset to recruiting, fund-raising, submitting IND to FDA, advancing in clinical development,…
Best Practices for Start-up Companies founded with Academic Technology
Best Practices for Start-up Companies founded with Academic Technology Date: 02/20/2015 Time: 3:30 pm – 4:30 pm Location: 123 Snell Library Speaker: Mark Tepper, CFP, President and Founder, Strategic Wealth Partners Best Practices for Start-up Companies founded with Academic Technology Come learn how to make smart financial decisions as an entrepreneur — from growing and…
Development of Technologies for Vision Impairment
Development of Technologies for Vision Impairment Date: 02/13/2015 Time: 3:30 pm – 4:30 pm Location: 123 Snell Library Speaker: Ramgopal Rao , CEO, 2C Tech Corporation, Inc. Development of Technologies for Vision Impairment Sixteen million Americans suffer from various ocular diseases, including retinitis pigmentosa, retinal detachment, diabetic retinopathy, and macular degeneration, which ultimately lead…
Validation and Integration of ‘Omic Information for Personalized Medicine
Validation and Integration of ‘Omic Information for Personalized Medicine Date: 02/06/2015 Time: 3:30 pm – 4:30 pm Location: 123 Snell Library Speaker: David de Graaf, President and CEO, Selventa Validation and Integration of ‘Omic Information for Personalized Medicine Selventa develops systems diagnostic tests for personalized medicine in disease areas such as autoimmune disorders, oncology, and…
Bio-inspired Biotechnology and Nanotechnology Drug Delivery Platforms
Bio-inspired Biotechnology and Nanotechnology Drug Delivery Platforms Date: 01/23/2015 Time: 3:30 am – 4:30 am Location: 123 Snell Library Speaker: Trevor P. Castor, President and CEO, Aphios Corporation Bio-inspired Biotechnology and Nanotechnology Drug Delivery Platforms Come learn about how Aphios is developing green, bio-inspired biotechnology and nanotechnology drug delivery platforms to improve the discovery and…
Targeted Nanoparticles for Mitochondrial Medicine
Targeted Nanoparticles for Mitochondrial Medicine Date: 11/25/2014 Time: 4:35 pm – 5:30 pm Location: 121 Snell Library Speaker: Shanta Dhar, NanoTherapeutics Research Laboratory, Department of Chemistry, University of Georgia Targeted Nanoparticles for Mitochondrial Medicine The potential benefits of integrating nanomaterials with properties such as biodegradability, magnetization, fluorescence, and near-infrared absorption into a single object of…
Targeting tumor vasculature and microenvironment for nanomedicine
Targeting tumor vasculature and microenvironment for nanomedicine Date: 11/21/2014 Time: 3:25 pm – 4:30 pm Location: 121 Snell Library Speaker: Dai Fukumura, MD, PhD , Edwin L. Steele Laboratory, Department of Radiation Oncology, MGH, Harvard Medical School Targeting tumor vasculature and microenvironment for nanomedicine Blood vessels in solid tumors have abnormal and heterogeneous organization, structure,…
The Promise of MiRNA-targeted Cancer Nanotherapy
The Promise of MiRNA-targeted Cancer Nanotherapy Date: 11/18/2014 Time: 4:35 pm – 5:35 pm Location: 121 Snell Library Speaker: Zdravka Medarova, PhD, Assistant Professor in Radiology, Harvard Medical School The Promise of MiRNA-targeted Cancer Nanotherapy Presently, chemotherapy is the mainstay therapy for metastatic cancer. However, considering the disadvantages of standard chemotherapy, e.g. non-specific delivery, toxicity…